Harris Shelton’s Fentress to Discuss Intellectual Property Issues for Export to China
Harris Shelton Hanover Walsh, PLLC (Tennessee, USA) partner Susan Fentress will participate on a panel at “China – The New Frontier for Export,” and event being held at the
University of Memphis on January 25, 2011. Ms. Fentress will discuss patent law basics for companies exporting to China.
Ms. Fentress concentrates her practice in the areas of intellectual property and biosciences. Ms. Fentress has extensive experience in the preparation and prosecution of chemical and biotech patent applications. In addition, she is particularly knowledgeable in the area of medical diagnostics, both immunological and DNA based testing, medical imaging agents, food technologies, agricultural products and disposable medical and personal devices and natural and veterinarian products. Ms. Fentress is also knowledgeable regarding FDA and transactional issues relating to medical devices and generic drugs, and she is experienced in international and U.S. regulatory issues relating to the design, production and distribution of medical devices.
Harris Shelton Hanover Walsh, PLLC partner Susan Fentress will participate on a panel at “China – The New Frontier for Export,” and event being held at the University of Memphis on January 25, 2011. Ms. Fentress will discuss patent law basics for companies exporting to China.
Ms. Fentress concentrates her practice in the areas of intellectual property and biosciences. Ms. Fentress has extensive experience in the preparation and prosecution of chemical and biotech patent applications. In addition, she is particularly knowledgeable in the area of medical diagnostics, both immunological and DNA based testing, medical imaging agents, food technologies, agricultural products and disposable medical and personal devices and natural and veterinarian products. Ms. Fentress is also knowledgeable regarding FDA and transactional issues relating to medical devices and generic drugs, and she is experienced in international and U.S. regulatory issues relating to the design, production and distribution of medical devices.
